PHELINUN 200 mg Pulver und Lösungsmittel für ein Konzentrat zur Herstellung einer Infusionslösung New

Recall | Medicines | 22/12/2025

The distribution partner informed its customers on December 22, 2025, that the information stated on the label is not consistent with the labelling of the active substance content and is mutually exclusive. To prevent any potential risk to patients resulting from incorrect dosing, the two affected batches are being recalled. 

The medicinal product is authorised in Poland and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.

Name of the medicinal product PHELINUN 200 mg Pulver und Lösungsmittel für ein Konzentrat zur Herstellung einer Infusionslösung
Marketing authorisation number(s) EU/1/20/1487/002
Marketing authorisation holder Adienne S.r.l.
Distributor Stelopharm GmbH
Batch number(s) Batch, Expiry Date
24P012, 03/2026
24P005, 12/2025
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-5450
Email

Further inquiry note